RoukenBio & Avs Bio  300 x 75 white

Biologics Symposium 2026 – Dutch edition:

Designing tomorrow’s therapies

Location: Accelerator Building - Utrecht
  Date: June 2
 
Free to attend*

Explore the Agenda

About Biologics Symposium 2026



Advanced biologics are reshaping therapeutic innovation, combining engineered proteins, antibodies, and cellular approaches to target disease with exceptional precision. The Netherlands hosts one of Europe’s most dynamic and collaborative immunotherapy ecosystems, making it an ideal setting to connect with leading experts and innovative companies.

Together we will explore:

•    Early characterization strategies that reduce downstream surprises
•    Innovative biologics platforms for oncology and beyond
•    Emerging targets and new mechanism of action
•    Novel antibody formats and functional profiling of mono-  and multi-specific antibodies 

Come for the insights. Stay for the conversations that move programs forward.

iStock-2175720313

Confirmed speakers

Hear from industry experts.

Bart-Jan de Kreuk

Bart-Jan de Kreuk

Associate Director, Genmab
Casper

Casper Marsman

Sr. Scientist, Kling Biotherapeutics
Bart-Jan de Kreuk (1)

Dr Louis Boon

CSO & Board Member, JJP Biologics
Joost Uitdehaag

Joost Uitdehaag

Head of Biology, Crossfire Oncology
Agapitos Patakas

Agapitos Patakas, PhD

CSO, RoukenBio
Ilse AVS Bio

Ilse Roodink, PhD

CSO, AVS Bio
Madelon Maurice-2

Madelon Maurice

UMC Utrecht and Oncode Institute
Lars Guelen, PhD-1

Lars Guelen, PhD

Head of Protein Development,Tagworks Pharmaceuticals
Erik D Principal consultant at Doevendans Consultancy

Erik Doevendans

Principal Consultant, Doevendans Consultancy
Maurits den Boer

Maurits den Boer

CEO and Co-Founder, Abvion Bio
HubSpot Landing Page  Delegate profiles (1)

Renier Heijkants

Principal Scientist, Byondis
HubSpot Landing Page  Delegate profiles (2)

Kristof Vercruysse

CEO, TargEd
HubSpot Landing Page  Delegate profiles (3)

Jan-Jaap Verhoef

CEO and Founder, ImmunoTx
HubSpot Landing Page  Delegate profiles (5)

Néstor Vázquez Bernat

Scientific Solutions Consultant, Cradle
HubSpot Landing Page  Delegate profiles (6)

Marleen van Loenen 

Executive Director, Head of Discovery, T-knife
Jana Obajdin

Jana Obajdin

Analyst, BioGeneration Ventures
Floris Hamel

Floris Hamel

Senior Investment Manager and Team Lead, BOM
charlotte

Charlotte Koldeweij 

Analyst, Forbion
Adele RoukenBio-1

Adele Hannigan

CBO, RoukenBio
valentina

Valentina Vignali

Investment Professional, Utrecht Holdings

Why attend

 Designed as a high-value environment where participants can connect, exchange expertise, build collaborations and identify practical routes to bring biologics to patients faster and more effectively. 

Screenshot 2026-05-19 134806
Screenshot 2026-05-19 134846
Insightful conversations and talks
Research poster sessions
Networking opportunities

Research posters

 Abstracts can be submitted for a poster presentation via the registration form.

How to get to the venue 

Getting to The Accelerator

Address: Uppsalalaan 17, 3584 CT Utrecht

  • By tram (fastest from Utrecht Central Station): Take Tram 22 toward P+R Science Park and get off at the final stop. The building is a 3‑minute walk back toward the city.
  • By bus: Take Bus 28 toward P+R Science Park and exit at the final stop.
  • By bicycle: A 15–20 minute ride from Utrecht city centre; secure bike parking is available at the building entrance.
  • By car: From the A28, take Exit 2 (Utrecht Science Park). Parking is available at P+R Science Park (Uppsalalaan 7), directly adjacent to the venue.

 

About the organisers

Antibody Analytics - The Creative Collaborative Consultative Immunology CRO - 01

RoukenBio - Immunology CRO redefined is providing discovery to IND-enabling immunology and bioassay research services to a global customer base in the therapeutic areas of inflammation, auto-immunity, immuno-oncology, oncology and beyond. Our vision is to become the most trusted research partner for biotherapeutic innovators.

Backed by our brilliant minds, we have turned the traditional CRO model on its head by fostering a collaborative and personalised approach.

Our mission is simple: Solve problems. Deliver quality data. Propel your drug discovery breakthroughs.

avsbio-logo=royal-blue


AVS Bio
is a global company supporting the development of biologics for animal and human health with products and services at its operational sites in North America and Europe.

AVS Bio offers design-driven antibody discovery and development services, tailored to target insights and lead antibody requirements. Since 2018, AVS Bio has supported more than 100 life sciences companies launch successful lead antibody programs, including the development of 10 antibodies that entered clinical trials.

AVS Bio completed over 3,250 standalone protein production and purification programs over the past decades.

Our clients trust us for our expertise, efficiency, and commitment to turning complex challenges into successful outcomes.

* Registration is open exclusively to therapeutic developers and academics. If you do not fall into these categories, please email hello@rouken.bio to request permission to attend.